Cited by 11Hedgehog Signaling Pathway StudiesHippo pathway signaling and YAP/TAZWnt/β-catenin signaling in development and cancer

Non-cell-autonomous signaling by Shh in tumors: challenges and opportunities for therapeutic targets

Open access
Bijlsma, Maarten F, Roelink, Henk·2010·Expert Opinion on Therapeutic Targets

Abstract

IMPORTANCE OF THE FIELD: The Hedgehog (Hh) pathway is required during many developmental events; in adults the Hedgehog pathway is involved in the maintenance of several stem cell niches. It is therefore not surprising that aberrantly regulated Hh pathway activity can cause birth defects in the developing organism, as well as neoplastic disease later in life. AREAS COVERED IN THIS REVIEW: As a consequence of the involvement in pathogenesis, the Hh pathway components are subject to an intense scrutiny as potential targets for therapeutic agents. We aim to provide an overview of the biology of the Hh proteins and the cellular response, in conjunction with potential therapeutic interventions. WHAT THE READER WILL GAIN: Specifically, we focus on the recently discovered non-cell-autonomous Shh signaling used by tumors and the implications of this for the design of treatment strategies. This should provide the reader with up-to-date knowledge on the role of the Hh pathway in tumor progression and the options to treat these malignancies. TAKE HOME MESSAGE: An important concept that we advocate in this review is the need to recognize the need to target both the stromal and the tumor compartment in malignancies that rely on paracrine Shh signaling.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/14728222.2010.497488

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IFT80 can repress SHH-mediated noncanonical activation of the GTPase RHOA in differentiating mouse osteoblasts.

    “For example, the IFT-B complex protein, IFT80, can repress SHH-mediated noncanonical activation of the GTPase RHOA in differentiating mouse osteoblasts 108,”

    From Cellular signalling by primary cilia in development, organ function and disease (2019) · cites this paper as [108]

    The Hedgehog signal transduction section describes a transcription-independent Shh response, supporting the general reference to noncanonical signaling. It does not identify IFT80, RHOA, or differentiating mouse osteoblasts, so it does not support the specific repression mechanism claimed. Page numbers are unavailable in our copy. (LLM, conf=0.81)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bijlsma, M. F., & Roelink, H.
Affiliations
University of California, Berkeley (US)
Corresponding author
Roelink, Henk
Venue
Expert Opinion on Therapeutic Targets
Published
2010-06
Volume
14
Issue
7
Pages
693-702
ISSN
  • 1472-8222 (ISSN-L)
  • 1744-7631
OpenAlex
W1988419972
Cited by
11
References
89
Citations by year
2024: 1 · 2019: 1 · 2016: 2 · 2015: 4 · 2014: 3
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Expert Opinion on Therapeutic Targets (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
Funders
National Institute of General Medical Sciences (R01GM097035)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
Keywords
Sonic hedgehog, Hedgehog signaling, non-cell-autonomous signaling, paracrine signaling, tumor microenvironment, tumor stroma, therapeutic target, tumor progression, cancer therapy
MeSH terms
Acylation, Animals, Antineoplastic Agents, Endocytosis, Humans, Ligands, Neoplasms, Protein Processing, Post-Translational, Stromal Cells, Paracrine Communication, Intercellular Signaling Peptides and Proteins, Hedgehog Proteins, Stem Cell Niche, Secretory Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review